About the treatment
Therapeutic apheresis operates at the interface between the circulatory system and targeted extracorporeal processing. Blood is diverted through a closed circuit where plasma is separated from the cellular fraction and then selectively managed before recombination and return. This allows direct modulation of the soluble milieu that bathes every tissue in the body.
At Elysium we employ plasma-focused apheresis modalities that address the complex mixture of proteins, lipoproteins, cytokines and metabolic intermediates circulating at any given time. By exerting precise control over what is removed and what is retained, the therapy influences downstream signalling pathways, inflammatory tone and cellular microenvironments without relying on pharmacological agents.
The approach is grounded in the understanding that many age-related and lifestyle-driven processes are reflected in, and reinforced by, the composition of plasma itself. For individuals who already optimise nutrition, movement and recovery yet still observe diminishing returns, therapeutic apheresis offers a rational next layer of intervention. It works upstream of cellular function, creating conditions in which the body’s own regulatory systems can operate with less interference.
This makes it a considered elective choice for those seeking to maintain high physiological performance over decades rather than reacting once function has noticeably declined.
Treatments
